Wednesday, 04 June 2020
Ferring and Igenomix collaborate to advance care in reproductive medicine and maternal health
Read press release
Wednesday, 13 May 2020
Swissmedic approves Carbetocin Ferring for the prevention of postpartum haemorrhage in all births
Read press release
Wednesday, 06 May 2020
Rebiotix and Ferring announce world’s first with positive preliminary pivotal Phase 3 data for investigational microbiome-based therapy RBX2660
Read press release
Wednesday, 18 March 2020
Ferring Statement on the COVID-19 (novel coronavirus disease) Pandemic and Reproductive Medicine
Read press release
Tuesday, 04 Febuary 2020
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660
Thursday, 23 Janaury 2020
Ferring’s Propess® is the first pharmacological treatment for cervical ripening to be approved in Japan for over 20 years
Wednesday, 18 December 2019
FerGene Appoints David Meek Chief Executive Officer
Read press release
Thursday, 5 December 2019
FerGene announces pivotal Phase 3 study of nadofaragene firadenovec met its primary endpoint with more than half of patients with high-grade non-muscle invasive bladder cancer (CIS ± Ta/T1) achieving a complete response at three months
Read press release
Monday, 25 November 2019
Ferring and Blackstone Life Sciences invest over $570 million USD in novel gene therapy for bladder cancer patients
Read press release
Tuesday, 09 July 2019
Heat-stable carbetocin has been added to the WHO Essential Medicines List for the prevention of excessive bleeding after childbirth
Read press release
Monday, 01 July 2019
Ferring announces changes to Executive Committee
Read press release
Wednesday, 19 June 2019
Ferring collaboration with digital health innovators WOOM aims to help more people build families faster
Read press release
Monday, 18 March 2019
Ferring statement on subsidised pricing of heat-stable carbetocin for the prevention of postpartum haemorrhage in low- and lower-middle income countries
Read press release
Tuesday, 22 January 2019
Ferring, Rebiotix and Karolinska Institutet extend collaboration to research next generation of microbiome treatments
Read press release
Monday, 03 December 2018
Ferring announces recipients of 2018-19 Innovation Grants
Read press release
Wednesday, 31 October 2018
Ferring announces retirement of Michel Pettigrew, President of the Executive Board and Chief Operating Officer
Read press release
Wednesday, 17 October 2018
Ferring and Evotec form strategic research alliance in reproductive medicine and women’s health
Read press release
Thursday, 30 August 2018
Ferring and Celmatix launch ambitious genomics collaboration to advance care in reproductive medicine and women’s health
Read press release
Monday, 02 July 2018
New analysis of Rekovelle® data further supports use of AMH to personalise fertility treatment
Read press release
Wednesday, 27 June 2018
Ferring’s heat-stable carbetocin could save thousands of women’s lives by preventing excessive bleeding after childbirth
Read press release
Thursday, 03 May 2018
Ferring signs global agreement to commercialise novel gene therapy for bladder cancer patients
Read press release
Thursday, 05 April 2018
Ferring acquires innovative biotechnology company and microbiome pioneer Rebiotix Inc.
Read press release
Friday, 16 March 2018
Nocturia: the most common cause of a poor night’s sleep1, say experts on World Sleep Day
Read press release
Thursday, 15 March 2018
Ferring announces positive outcome of European Decentralised Procedure (DCP) for Testavan®, a treatment for men with hypogonadism
Read press release
Wednesday, 07 March 2018
March of Dimes and Ferring announce new Prematurity Research Center at Imperial College London
Read press release
Thursday, 22 February 2018
Ferring Pharmaceuticals and MSD Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Haemorrhage
Read press release
Wednesday, 14 February 2018
Ferring announces 30 million CHF investment in new biotech centre in Switzerland
Read press release
Friday, 26 January 2018
Ferring Announces Recipients of Innovation Grants Program 2017-2018
Read press release
Monday, 22 January 2018
Ferring enters into worldwide OmniAb® platform license agreement with Ligand
Read press release
Wednesday, 10 January 2018
VITAROS®
Weiter zur Pressemitteilung
